Key Financial Data Of Reporting Company

SUSMED, Inc. - Filing #7276908

Concept As at
2024-12-31
2024-07-01 to
2024-12-31
As at
2024-06-30
2023-07-01 to
2024-06-30
2023-07-01 to
2023-12-31
As at
2023-12-31
Key financial data of reporting company
Business results of reporting company
Ordinary profit (loss)
-309,842,000 JPY
-357,222,000 JPY
-90,767,000 JPY
Profit (loss)
-313,158,000 JPY
-357,415,000 JPY
-91,397,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
97,203,000 JPY
80,963,000 JPY
69,781,000 JPY
Total number of issued shares
16,812,900 xbrli:shares
16,759,300 xbrli:shares
16,685,800 xbrli:shares
Net assets
4,337,956,000 JPY
4,604,297,000 JPY
4,841,547,000 JPY
Total assets
4,683,880,000 JPY
4,932,086,000 JPY
5,172,011,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-18.67
-21.41
-5.49
Diluted earnings per share
Equity-to-asset ratio
0.919 xbrli:pure
0.929 xbrli:pure
0.933 xbrli:pure
Net cash provided by (used in) operating activities
-275,242,000 JPY
-230,762,000 JPY
21,447,000 JPY
Net cash provided by (used in) investing activities
-14,092,000 JPY
-8,528,000 JPY
-3,697,000 JPY
Net cash provided by (used in) financing activities
-378,000 JPY
37,372,000 JPY
15,061,000 JPY
Cash and cash equivalents
4,557,208,000 JPY
4,846,920,000 JPY
5,081,649,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.